Annette Paschen

7.1k total citations
90 papers, 3.2k citations indexed

About

Annette Paschen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Annette Paschen has authored 90 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Immunology, 51 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Annette Paschen's work include Immunotherapy and Immune Responses (48 papers), CAR-T cell therapy research (29 papers) and Immune Cell Function and Interaction (24 papers). Annette Paschen is often cited by papers focused on Immunotherapy and Immune Responses (48 papers), CAR-T cell therapy research (29 papers) and Immune Cell Function and Interaction (24 papers). Annette Paschen collaborates with scholars based in Germany, United States and Spain. Annette Paschen's co-authors include Dirk Schadendorf, Antje Sucker, Klaus Griewank, Bastian Schilling, Fang Zhao, Federico Garrido, Francisco Ruiz‐Cabello, Jürgen C. Becker, Alexander Steinle and Adelheid Cerwenka and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Annette Paschen

86 papers receiving 3.2k citations

Peers

Countries citing papers authored by Annette Paschen

Since Specialization

Citations

This map shows the geographic impact of Annette Paschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Paschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Paschen more than expected).

Fields of papers citing papers by Annette Paschen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Paschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Paschen. The network helps show where Annette Paschen may publish in the future.

Co-authorship network of co-authors of Annette Paschen

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Paschen. A scholar is included among the top collaborators of Annette Paschen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Paschen. Annette Paschen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single‐cell transcriptomics and epigenomics point to CD58‐CD2 interaction in controlling primary melanoma growth and immunity 2025 ·Cancer Communications ·(unknown), Maria Schmidt, (unknown), (unknown), Carolyn J. Schultz, (unknown), Henry Loeffler‐Wirth, Stephan Wolf, Frank Große, (unknown), Annette Paschen, Ulf Anderegg, Jan C. Simon, Mirjana Ziemer, Clara T. Schoeder, Hans Binder, Manfred Kunz	0
2	Orthanq: transparent and uncertainty-aware haplotype quantification with application in HLA-typing 2024 ·BMC Bioinformatics ·(unknown), Annette Paschen, Dirk Schadendorf, Johannes Köster	0
3	HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance 2023 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), Anne Zaremba, (unknown), (unknown), Antje Sucker, (unknown), Gennadiy Zelinskyy, Soldano Ferrone, Alexander Roesch, Susanne Horn, Eva Hadaschik, Dirk Schadendorf, Mirko Trilling, Ulf Dittmer, Klaus Griewank, Fang Zhao, Annette Paschen	9
4	Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors 2023 ·Frontiers in Immunology ·(unknown), George Papafotiou, (unknown), (unknown), Annette Paschen, Thomas Blankenstein, Gerald Willimsky	3
5	Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells 2021 ·Life ·(unknown), (unknown), (unknown), Jürgen C. Becker, Annette Paschen, Dirk Jäger, Winfried S. Wels, Michael Bachmann, Jessica C. Hassel	10
6	Melanoma Differentiation Trajectories Determine Sensitivity toward Pre-Existing CD8+ Tumor-Infiltrating Lymphocytes 2021 ·Journal of Investigative Dermatology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Heike Chauvistré, Pietro Crivello, Katharina Fleischhauer, Alexander Roesch, Antje Sucker, Dirk Schadendorf, Yong Chen, Annette Paschen, Fang Zhao	7
7	Direct RIG‐I activation in human NK cells induces TRAIL‐dependent cytotoxicity toward autologous melanoma cells 2018 ·International Journal of Cancer ·Juliane Daßler‐Plenker, Annette Paschen, (unknown), (unknown), (unknown), Marion Goldeck, Eva Bartok, Gunther Hartmann, Christoph Coch	26
8	Frequent GNAQ, GNA11 , and EIF1AX Mutations in Iris Melanoma 2017 ·Investigative Ophthalmology & Visual Science ·Simone L. Scholz, Inga Möller, Henning Reis, Daniela Süßkind, Johannes A.P. van de Nes, Sonia Leonardelli, Bastian Schilling, Elisabeth Livingstone, Tobias Schimming, Annette Paschen, Antje Sucker, Rajmohan Murali, Klaus‐Peter Steuhl, Dirk Schadendorf, Henrike Westekemper, Klaus Griewank	26
9	Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma 2017 ·Scientific Reports ·Cathrin Ritter, Kaiji Fan, Annette Paschen, (unknown), Soldano Ferrone, Paul Nghiem, Selma Ugurel, David Schrama, Jürgen C. Becker	107
10	Activated Tissue-Resident Mesenchymal Stromal Cells Regulate Natural Killer Cell Immune and Tissue-Regenerative Function 2017 ·Stem Cell Reports ·(unknown), Alexander Hackel, (unknown), Claudia A. Dumitru, Kirsten Bruderek, Stefanie B. Flohé, Annette Paschen, Stephan Lang, Sven Brandau	75
11	Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency 2016 ·Cancer Research ·Fang Zhao, Antje Sucker, Susanne Horn, (unknown), Nicola Bielefeld, Barbara Schrörs, Anne Bicker, Monika Lindemann, Alexander Roesch, Gustav Gaudernack, Mathias Stiller, Jürgen C. Becker, Volker Lennerz, Thomas Wölfel, Dirk Schadendorf, Klaus Griewank, Annette Paschen	57
12	Exposure to Melan-A/MART-126-35 tumor epitope specific CD8+T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS) 2016 ·Scientific Reports ·Frédéric Ebstein, Martin D. Keller, Annette Paschen, Peter Walden, Michael Seeger, (unknown), Elke Krüger, Dirk Schadendorf, Peter‐M. Kloetzel, Ulrike Seifert	16
13	Deciphering the genetic evolution of T-cell resistance in melanoma 2015 ·OncoImmunology ·Antje Sucker, Annette Paschen	3
14	Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression 2014 ·Clinical Cancer Research ·Antje Sucker, Fang Zhao, Birgit Real, (unknown), Nicola Bielefeld, (unknown), Susanne Horn, Iris Moll, Raffaela Maltaner, Peter A. Horn, Bastian Schilling, Francesco Sabbatino, Volker Lennerz, Matthias Kloor, Soldano Ferrone, Dirk Schadendorf, Christine S. Falk, Klaus Griewank, Annette Paschen	127
15	Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell–Activating Receptor NKp30 2014 ·Cancer Research ·Eva Schlecker, Nathalie Fiegler, Annette Arnold, Peter Altevogt, Stefan Rose‐John, Gerhard Moldenhauer, Antje Sucker, Annette Paschen, Elke Pogge von Strandmann, Sonja Textor, Adelheid Cerwenka	169
16	Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D 2011 ·Cancer Research ·Anja Heinemann, Fang Zhao, Sonali Pechlivanis, Jürgen Eberle, Alexander Steinle, Sven Diederichs, Dirk Schadendorf, Annette Paschen	167
17	Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries 2010 ·PLoS ONE ·Wolfram Osen, Sabine Soltek, Mingxia Song, Barbara Leuchs, Julia Steitz, Thomas Tüting, Stefan B. Eichmüller, (unknown), Dirk Schadendorf, Annette Paschen	16
18	A Novel Strategy for the Discovery of MHC Class II–Restricted Tumor Antigens: Identification of a Melanotransferrin Helper T-Cell Epitope 2005 ·Cancer Research ·Till A. Röhn, (unknown), Annette Paschen, Xuan Duc Nguyen, Dirk Schadendorf, Anne B. Vogt, Harald Kropshofer	32
19	MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma 2004 ·Cancer Gene Therapy ·(unknown), Annette Paschen, (unknown), (unknown), Walter Mier, (unknown), J A Kleinschmidt, Dirk Schadendorf, Uwe Haberkorn	16
20	Rhodobacter capsulatus nifAmutants mediatingnifgene expression in the presence of ammonium 2001 ·FEMS Microbiology Letters ·Annette Paschen, Thomas Drepper, Bernd Masepohl, Werner Klipp	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact